• David Hartell

CNTRP Project 2 researchers in the news

Dr. Greg Knoll, CNTRP Project 2 Lead, and Dr. Amit Garg, Project 2 member, both recently published important studies looking at outcomes for kidney transplant recipients and living kidney donors.

Dr. Knoll and colleagues showed that among kidney transplant recipients, a three-month course of the antibiotic levofloxacin following transplantation did not prevent the major complication known as BK virus from appearing in the urine. The intervention was associated with an increased risk of adverse events such as bacterial resistance, according to their study appearing in the November issue of JAMA. These findings are significant because they do not support the use of levofloxacin to prevent post-transplantation BK virus infection. READ MORE.

In a study published in the New England Journal of Medicine, Dr. Amit Garg and colleagues found that living kidney donors were more likely to be diagnosed with gestational hypertension (high blood pressure) or preeclampsia than non-donors. The retrospective cohort study looked at living kidney donors who became pregnant and matched them with pregnant non-donors screened for similar baseline good health. The study found that donors have approximately a one in 10 chance of developing gestational hypertension or preeclampsia in a pregnancy after donation as compared to the expected chance in non-donors of one in 20. Dr. Garg and colleagues stress that while living kidney donors were more likely to be diagnosed with gestational hypertension or preeclampsia than non-donors, there were no other differences between the two groups including important maternal and fetal outcomes. READ MORE

#kidneydonation #media

  • Black Facebook Icon
  • Black Twitter Icon
  • Black YouTube Icon

© 2014 by the CDTRP

All rights reserved